SCHEMBL19923686

SCHEMBL19923686

CN1C(=O)N([Si](c2ccccc2)(c2ccccc2)c2ccccc2)C(C)(C)C1=O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.37
BACE1 P56817 5/20 0.36
BACE2 Q9Y5Z0 3/20 0.36
REN P00797 1/20 0.36
APP P05067 1/20 0.36
PLA2G7 Q13093 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.35
MAPT P10636 3/20 0.34
MAPK1 P28482 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
HSD17B10 Q99714 1/20 0.34
KDM4C Q9H3R0 1/20 0.34
GRM5 P41594 2/20 0.34
ELANE P08246 1/20 0.33
KDM4E B2RXH2 2/20 0.32
LMNA P02545 2/20 0.32
HCRTR1 O43613 1/20 0.32
TSHR P16473 1/20 0.32
CASP3 P42574 1/20 0.32
CYP2C19 P33261 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19923515 0.83 ALDH1A1 (0.37) ALDH1A1PLA2G7ELANE
SCHEMBL19923754 0.82 HTR1A (0.41) ALDH1A1BACE1BACE2RENAPP
SCHEMBL19923652 0.81 TSHR (0.38) ALDH1A1BACE1BACE2RENAPP
SCHEMBL19923638 0.72 PLA2G7 (0.45) ALDH1A1BACE1BACE2RENAPP
SCHEMBL19923738 0.71 LMNA (0.37) ALDH1A1KDM4ELMNA
SCHEMBL19923514 0.69 ALDH1A1 (0.41) ALDH1A1BACE1BACE2RENAPP
SCHEMBL19923559 0.68 HTR1A (0.42) ALDH1A1BACE1BACE2RENAPP
SCHEMBL19923547 0.67 ELANE (0.49) ELANELMNATSHRCYP2C19KMT2A
SCHEMBL19923632 0.67 USP2 (0.35) ALDH1A1SMN1; SMN2GRM5
SCHEMBL19923558 0.67 ELANE (0.41) ALDH1A1SMN1; SMN2ELANEKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10899718-B2 Polymers functionalized with N-protected hydantoin compounds BRIDGESTONE CORPORATION (JP) 2021-01-26 US claimed
US-20180065935-A1 POLYMERS FUNCTIONALIZED WITH N-PROTECTED HYDANTOIN COMPOUNDS BRIDGESTONE CORPORATION (JP) 2018-03-08 US claimed
US-10899718-B2 Polymers functionalized with N-protected hydantoin compounds BRIDGESTONE CORPORATION (JP) 2021-01-26 US disclosed
US-20180065935-A1 POLYMERS FUNCTIONALIZED WITH N-PROTECTED HYDANTOIN COMPOUNDS BRIDGESTONE CORPORATION (JP) 2018-03-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180065935-A1 POLYMERS FUNCTIONALIZED WITH N-PROTECTED HYDANTOIN COMPOUNDS PARG, HNMT, PARN ALDH1A1 2648/4885BACE1 4315/4885BACE2 4642/4885
US-10899718-B2 Polymers functionalized with N-protected hydantoin compounds HNMT, PARG, PAM ALDH1A1 2554/4885BACE1 4432/4885BACE2 4717/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.